Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parameters of immunotherapy: a retrospective study

A Malet1, M Lluch, A Valero

  • 1Al-lergo Centre, Barcelona, Spain.

Allergologia Et Immunopathologia
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study.

Journal of investigational allergology & clinical immunology·2022
Same author

Search for Lepton-Flavor Violation in Z-Boson Decays with τ Leptons with the ATLAS Detector.

Physical review letters·2022
Same author

Economic Consequences of the Overuse of Short-Acting ß-Adrenergic Agonists in the Treatment of Asthma in Spain.

Journal of investigational allergology & clinical immunology·2021
Same author

Search for New Phenomena in Final States with Two Leptons and One or No b-Tagged Jets at sqrt[s]=13  TeV Using the ATLAS Detector.

Physical review letters·2021
Same author

Usefulness of the Nasal Allergen Provocation Test in the Diagnosis of Shellfish Allergy.

Journal of investigational allergology & clinical immunology·2021
Same author

Search for Displaced Leptons in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2021
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Gastrointestinal stenosis: an underrecognized complication of CARMIL2 deficiency.

Allergologia et immunopathologia·2026
Same journal

Peach sublingual immunotherapy for lipid transfer protein syndrome.

Allergologia et immunopathologia·2026
Same journal

Vitamin B12 allergy and desensitization.

Allergologia et immunopathologia·2026
Same journal

Chronic HBV infection, stemness pathways, and compromised immune surveillance in HCC development.

Allergologia et immunopathologia·2026
Same journal

Application of FeNO in the diagnostic and therapeutic algorithm of pediatric asthma: From chronic cough and wheeze to personalized management.

Allergologia et immunopathologia·2026
See all related articles

Immunotherapy for respiratory diseases involving Dermatophagoides pteronyssinus (DPT) showed a decrease in specific IgE and IgG1 levels. Specific IgG4 levels initially increased then decreased, with no correlation to clinical outcomes.

Area of Science:

  • Allergy and Immunology
  • Respiratory Medicine
  • Immunotherapy Research

Background:

  • Immunotherapy (IT) is a treatment for allergic respiratory diseases.
  • Previous studies focused on specific IgG4 levels in DPT-sensitized patients undergoing IT.
  • Understanding subclass-specific IgG responses is crucial for evaluating IT efficacy.

Purpose of the Study:

  • To determine the subclass of specific IgG, IgG1, in patients undergoing IT for DPT sensitization.
  • To compare IgG1 levels with previously studied IgG4 levels during IT.
  • To analyze the dynamic changes in anti-DPT specific IgE, IgG1, and IgG4 during a 36-month IT period.

Main Methods:

  • A cohort of 26 DPT-sensitized patients with respiratory diseases received 36 months of IT.

Related Experiment Videos

  • Serum levels of anti-DPT specific IgE, IgG1, and IgG4 were measured every six months.
  • Statistical analysis was performed to assess changes in antibody levels and ratios over time.

    • Main Results:

    • Anti-DPT specific IgE levels decreased significantly after 12 months of IT.
    • Anti-DPT specific IgG1 levels decreased significantly after 30 months of IT.
    • Anti-DPT specific IgG4 levels initially increased (6-24 months) then decreased, remaining significantly higher than pre-treatment levels. The IgG4/IgG1 ratio increased significantly during IT.
    • No correlation was found between antibody levels and clinical evolution.

    Conclusions:

    • Immunotherapy leads to significant changes in specific IgE and IgG subclass levels in DPT-sensitized patients.
    • The dynamic shifts in IgG1 and IgG4 subclasses may serve as markers of IT response.
    • Further research is needed to elucidate the clinical relevance of these specific IgG subclass changes.